EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CLNN

CLNN

Clene Inc.

Next earnings Aug 12, 2026 · consensus $-0.38 EPS, $75.0K rev

Last earnings +8.5% on 2026-05-14

Avoid
$6.06
▲ +4.66%
$6.06▲ +41.59%
over 1Y
L $3.36EODHDH $12.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.7%
1W+2.9%
1M-9.4%
3M+28.7%
YTD+5.0%
1Y+41.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy

Conservative balance sheet (liabilities/equity -2.03x); but revenue fell -41.5% YoY.

Clene Inc. shows $200K in FY2025 revenue (-41.5% YoY), a -13086.5% net margin.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$723K$473K$654K$342K$200K
Gross profit—————
Operating income-$50.0M-$48.4M-$40.5M-$33.1M-$23.1M
Net income-$9.74M-$29.9M-$49.5M-$39.4M-$26.2M
Diluted EPS-$0.16————
Net margin-1347.2%-6325.2%-7569.4%-11520.5%-13086.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$89.9M
EV / EBITDA—
EV / Sales449.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-36.7%
FCF yield-26.0%

Quality & risk

ROIC (est.)—
Free cash flow-$18.6M
Total debt$23.7M
Net cash-$18.5M
Altman Z-Score-26.92 distress
Piotroski F-Score1/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+37.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-05-22
  2. 8-K Material agreement2026-05-14
  3. 10-Q Quarterly report2026-05-14
  4. 8-K Material agreement2026-05-05
  5. 8-K Reg FD disclosure2026-05-04
  6. DEF 14A Proxy statement2026-04-10
  7. 8-K Material agreement2026-03-17
  8. 10-K Annual report2026-03-17
  9. 8-K Earnings results2026-03-12

Recent filings

all on EDGAR ↗
4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗S-8Filing2026-06-05open ↗SDFiling2026-05-22open ↗8-KPeriod ending 2026-05-182026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗4Period ending 2026-05-212026-05-22open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthC
ProfitabilityF
Financial healthF
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$200K
-41.5% YoY
Net margin
-13086.5%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$200K-41.5%
Net income-$26.2M+33.6%
Operating income-$23.1M+30.2%
Diluted EPS-$0.16+85.5%
Cash & equivalents$5.19M-57.3%
Total assets$18.1M-33.7%
Total liabilities$35.7M-1.3%
Stockholders' equity-$17.6M-98.6%
Op.: -11541.5%L/E: -2.03x

Frequently asked

Is Clene Inc. (CLNN) a buy?
CLNN currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -2.03x); but revenue fell -41.5% YoY.
What is Clene Inc.'s quality score?
CLNN scores 27.999999999999996/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001822791, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 7:54:19 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Earnings history

beat/miss · move
2026-05-14Beat +58.4% est▲ +8.46%8-K ↗
2026-03-12Miss -47.2% est▲ +6.09%8-K ↗
2025-11-13Miss -43.7% est▼ -22.42%8-K ↗
2025-10-14Miss -43.7% est▲ +4.12%8-K ↗
2025-08-14Miss -61.6% est▼ -1.37%8-K ↗
2025-05-07—▼ -10.53%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple SclerosisBullish
globenewswire.com· 2026-06-22
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?Bullish
finance.yahoo.com· 2026-05-19
3 Growth Stocks Insiders Are Betting OnBullish
finance.yahoo.com· 2026-05-18
Hennessy Capital Investment VII And 2 Insider-Favored Growth Stocks To WatchBullish
finance.yahoo.com· 2026-05-18
Top Growth Companies With High Insider Ownership May 2026Bullish
finance.yahoo.com· 2026-05-15
3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%Bullish
finance.yahoo.com· 2026-05-15

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score28 vs 67
Revenue growth-41.5% vs 7.1%
Net margin-13086.5% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 17d
Bullish
+0.18
vs typical · 30 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.